All Outputs (2)

Oncology Activity (2016)
Book Chapter
Gill, J. H., & Shnyder, S. D. (2016). Oncology Activity. In F. J. Hock (Ed.), Drug discovery and evaluation : pharmacological assays (4157-4200). (4th ed.). Springer Verlag. https://doi.org/10.1007/978-3-319-05392-9_113

The development of therapeutics to treat cancer is conceptually more difficult than for nonlife-threatening diseases for several reasons, including its complex pathophysiological nature, the molecular individuality of each tumor, and the robustness a... Read More about Oncology Activity.

Oncology Pharmacology (2013)
Book Chapter
Gill, J. (2013). Oncology Pharmacology. In H. Vogel, J. Maas, F. Hock, & D. Mayer (Eds.), Drug discovery and evaluation : safety and pharmacokinetic assays (573-593). (2nd). Springer Verlag. https://doi.org/10.1007/978-3-642-25240-2_20

Cancer is a complex life-threatening disease with patients having a poor prognosis and significantly reduced life expectancy, factors which significantly alter the risk-benefit balance in this therapeutic area. In contrast to other therapeutic areas,... Read More about Oncology Pharmacology.